Latest News and Press Releases

MANAMA, Kingdom of Bahrain, Feb. 16, 2025 (GLOBE NEWSWIRE) -- The Bahrain Oncology Centre (BOC) has made medical history by successfully treating a sickle cell disease (SCD) patient...

Block & Leviton is investigating Cibus, Inc. for potential securities law violations. Investors who have lost money should contact the firm.

Cibus, Inc. investigated for potential securities law violations. Investors who have lost money in their Cibus investment should contact Block & Leviton.

Immunity enhanced silkworms provide licensing opportunities into the broader $14B1 silk industry ANN ARBOR, Mich., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB)...

ANN ARBOR, Mich., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and...

Immunity enhanced silkworms provide licensing opportunities into the broader $14 B1 silk industry ANN ARBOR, Mich., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:...

ANN ARBOR, Mich., Aug. 27, 2021 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), the leading developer of spider silk-based fibers, announces...

ANN ARBOR, Mich., Aug. 17, 2021 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), the leading developer of spider silk-based fibers, announces...

ANN ARBOR, Mich., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), the leading developer of spider silk based fibers, announces...

ANN ARBOR, Mich., June 23, 2021 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and...